Psaila, B., Nangalia, J., Gotlib, J., Harrison, C., Mascarenhas, J., Crowgey, E., Lamothe, B., Tian, C., Braunstein, E., Koschmieder, S. (2025). Molecular characterization of patients (pts) with myeloproliferative neoplasms treated with INCA033989 demonstrates selective targeting of CALR mutant hematopoietic cells. Blood. https://doi.org/10.1182/blood-2025-71